miR-137 inhibits melanoma cell proliferation through downregulation of GLO1
Late-stage melanoma is refractory to current therapies. MicroRNAs (miRNAs) can modulate many physiological and pathological processes of melanoma. Studies have demonstrated that miR-137 acts as a tumor suppressor by inhibiting the proliferation of melanoma cells through targeting multiple mRNAs. The glyoxalase system member glyoxalase 1 (GLO1) is the principal scavenging enzyme of methylglyoxal (MG), a toxic byproduct of glycolysis. Using 35S in vivo/vitro labelling analysis for dynamic proteomics (SiLAD), we found that miR-137 downregulated the expression of GLO1 in melanoma cells. Bioinformatics analysis predicted that GLO1 is a direct target of miR-137. This was validated by dual luciferase reporter assay. Quantitative RT-PCR (qRT-PCR) and western blot analysis indicated that miR-137 could decrease endogenous GLO1 expression. Furthermore, siRNA targeting of GLO1 mimicked inhibition of melanoma cell proliferation caused by miR-137 overexpression. Re-expression of GLO1 was able to restore miR-137-mediated suppression of melanoma cell proliferation. Therefore, these results suggest that miR-137 inhibits the proliferation of melanoma cells by targeting GLO1.
Keywordsmelanoma miR-137 SiLAD GLO1 cell proliferation
Unable to display preview. Download preview PDF.
This work was supported by the Special Funds for Major State Basic Research of China (2011CB915504), Coalition for National Science Funding (31171371 (2011–2015) to Dacheng He), and the German Cancer Aid (Melanoma Research Network) to Dr. Stefan B. Eichmüller.
- Althoff, K., Beckers, A., Odersky, A., Mestdagh, P., Köster, J., Bray, I.M., Bryan, K., Vandesompele, J., Speleman, F., Stallings, R.L., Schramm, A., Eggert, A., Sprüssel, A., and Schulte, J.H. (2013). MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A. Int J Cancer 133, 1064–1073.CrossRefPubMedGoogle Scholar
- Chen, C.C., Liu, T.Y., Huang, S.P., Ho, C.T., and Huang, T.C. (2015). Differentiation and apoptosis induction by lovastatin and ?-tocotrienol in HL-60 cells via Ras/ERK/NF-?B and Ras/Akt/NF-?B signaling dependent down-regulation of glyoxalase 1 and HMG-CoA reductase. Cell Signal 27, 2182–2190.CrossRefPubMedGoogle Scholar
- Liu, M., Lang, N., Qiu, M., Xu, F., Li, Q., Tang, Q., Chen, J., Chen, X., Zhang, S., Liu, Z., Zhou, J., Zhu, Y., Deng, Y., Zheng, Y., and Bi, F. (2011). miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells. Int J Cancer 128, 1269–1279.CrossRefPubMedGoogle Scholar
- Luo, C., Tetteh, P.W., Merz, P.R., Dickes, E., Abukiwan, A., Hotz-Wagenblatt, A., Holland-Cunz, S., Sinnberg, T., Schittek, B., Schadendorf, D., Diederichs, S., and Eichmüller, S.B. (2013). miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes. J Invest Dermatol 133, 768–775.CrossRefPubMedGoogle Scholar
- Segura, M.F., Hanniford, D., Menendez, S., Reavie, L., Zou, X., Alvarez-Diaz, S., Zakrzewski, J., Blochin, E., Rose, A., Bogunovic, D., Polsky, D., Wei, J., Lee, P., Belitskaya-Levy, I., Bhardwaj, N., Osman, I., and Hernando, E. (2009). Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci USA 106, 1814–1819.CrossRefPubMedPubMedCentralGoogle Scholar
- Xu, J.F., Huang, Z.Y., Lin, L., Fu, M.Q., Gao, Y.H., Shen, Y.L., Zou, Y.Z., Sun, A.J., Qian, J.Y., and Ge, J.B. (2014). miR-210 over-expression enhances mesenchymal stem cell survival in an oxidative stress environment through antioxidation and c-Met pathway activation. Sci China Life Sci 57, 989–997.CrossRefPubMedGoogle Scholar